Table 3.
Patients Treated in Chronic HIV-1 Infection | |
---|---|
Cell mediated immune responses | |
Slightly higher CD4+ LPR in patients with lower VL No relation in magnitude and breadth of CD8+ T cell responses with VL |
Garcia [4] |
Inverse correlation between CD4+ LPR and VL | Kilby [5] |
Positive correlation of both, CD4+ LPR and CD8+ breadth responses, with time off ART | Lévy [6] |
Inverse correlation between CD4+ LPR and CD8+ magnitude and breadth and VL | Andrés [7] |
No association between CD4+ and CD8+ responses and longer TtR | Angel [9] |
No association of CD4+ LPR with time off ART | Pialoux [10] |
No association of T cell responses and VL | Mothe B [11] |
High CD4+ responses but absence of CD8+ responses associated to higher VL and shorter time to restart ART | Papagno [13] |
Patients Treated During Acute HIV-1 Infection | |
No association between CD4+ and CD8+ responses and time off ART | Goujard [8] |
HIV antibodies | |
No association of NAb (pre-ATI) with VL set point | Li [14] |
anti-C5/gp41 increase from week 1-preATI associated with low VL | Huang [15] |
Inflammation markers | |
VL control associated with increase in TNFα and IL-6 from week 1-preATI | Huang [16] |
Higher VL associated with increase in CRP from week 1-preATI | Huang [15] |
Note: LPR: lymphoproliferative responses; VL: viral load; ART: antiretroviral therapy; NAb: neutralizing antibodies; ATI: analytical treatment interruption; TNFα: tumor necrosis factor alpha; CRP: c-reactive protein.